1-Hydroxyethylidene-1, 1-Diphosphonic Acid From China; Determinations, 31958-31959 [2016-11891]
Download as PDF
31958
Federal Register / Vol. 81, No. 98 / Friday, May 20, 2016 / Notices
in Nebraska for the purpose of
enhancing the species’ survival.
National Environmental Policy Act
The proposed activities in the
requested permits qualify as categorical
exclusions under the National
Environmental Policy Act, as provided
by Department of the Interior
implementing regulations in part 46 of
title 43 of the Code of Federal
Regulations (43 CFR 46.205, 46.210, and
46.215).
Public Availability of Comments
All comments and materials we
receive in response to these requests
will be available for public inspection,
by appointment, during normal business
hours at the address listed in the
ADDRESSES section of this notice.
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Authority
We provide this notice under section
10 of the Act (16 U.S.C. 1531 et seq.).
Michael G. Thabault,
Assistant Regional Director, Mountain-Prairie
Region.
[FR Doc. 2016–12000 Filed 5–19–16; 8:45 am]
BILLING CODE 4333–15–P
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[LLORB00000.L17110000.PH0000.LXSSH
1060000.16XL1109AF; HAG 16–0136]
Notice of Public Meeting for the Steens
Mountain Advisory Council
Bureau of Land Management,
Interior.
ACTION: Notice of public meeting.
AGENCY:
In accordance with the
Federal Land Policy and Management
Act and the Federal Advisory
Committee Act of 1972, and the U.S.
Department of the Interior, Bureau of
Land Management (BLM), the Steens
Mountain Advisory Council (SMAC)
will meet as indicated below:
DATES: Monday, June 20, 2016 from 8
a.m. to 5 p.m. for an all-day field tour
on the east side of Steens Mountain, and
Tuesday, June 21, 2016 from 8:30 a.m.
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:40 May 19, 2016
Jkt 238001
to 12 p.m., at the Frenchglen School,
Frenchglen, Oregon. Daily sessions may
end early if all business items are
accomplished ahead of schedule, or go
longer if discussions warrant more time.
Tara
Thissell, Public Affairs Specialist, BLM
Burns District Office, 28910 Highway 20
West, Hines, Oregon 97738, (541) 573–
4519, or email tthissell@blm.gov.
Persons who use a telecommunications
device for the deaf (TDD) may call the
Federal Information Relay Service
(FIRS) at 1(800) 877–8339 to contact the
above individual during normal
business hours. The FIRS is available 24
hours a day, 7 days a week, to leave a
message or question with the above
individual. You will receive a reply
during normal business hours.
FOR FURTHER INFORMATION CONTACT:
The
SMAC was initiated August 14, 2001,
pursuant to the Steens Mountain
Cooperative Management and Protection
Act of 2000 (Pub. L. 106–399). The
SMAC provides representative counsel
and advice to the BLM regarding new
and unique approaches to management
of the land within the bounds of the
Steens Mountain Cooperative
Management and Protection Area,
recommends cooperative programs and
incentives for landscape management
that meet human needs, and advises the
BLM on maintenance and improvement
of the ecological and economic integrity
of the area. Agenda items for the June
20 and 21 sessions include: A field tour
to Pike Creek, Frog Springs, and other
sites on the east side of Steens
Mountain; updates from the Designated
Federal Official and the Andrews/
Steens Resource Area Field Manager;
discussions regarding projects for the
Steens Mountain Comprehensive
Recreation Plan, inholder access, and
fencing in the No Livestock Grazing
Area; and regular business items such as
approving the previous meeting’s
minutes, member round-table, and
planning the next meeting’s agenda.
Any other matters that may reasonably
come before the SMAC may also be
addressed. The public may attend the
field tour but must provide their own
transportation. A public comment
period is available during the June 21
session. Unless otherwise approved by
the SMAC Chair, the public comment
period will last no longer than 30
minutes, and each speaker may address
the SMAC for a maximum of five
minutes. The public is welcome to
attend all sessions, including the field
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
tour, but must provide personal
transportation.
Rhonda Karges,
Andrews/Steens Resource Area Field
Manager.
[FR Doc. 2016–11948 Filed 5–19–16; 8:45 am]
BILLING CODE 4310–33–P
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–558 and 731–
TA–1316 (Preliminary)]
1-Hydroxyethylidene-1, 1Diphosphonic Acid From China;
Determinations
On the basis of the record 1 developed
in the subject investigations, the United
States International Trade Commission
(‘‘Commission’’) determines, pursuant
to the Tariff Act of 1930 (‘‘the Act’’),
that there is a reasonable indication that
an industry in the United States is
threatened with material injury by
reason of imports of 1hydroxyethylidene-1, 1-diphosphonic
acid (‘‘HEDP’’) from China, provided for
in subheading 2931.90.90 (statistical
reporting number 2931.90.9043) of the
Harmonized Tariff Schedule of the
United States, that are alleged to be sold
in the United States at less than fair
value (‘‘LTFV’’) and are allegedly
subsidized by the government of China.
Commencement of Final Phase
Investigations
Pursuant to section 207.18 of the
Commission’s rules, the Commission
also gives notice of the commencement
of the final phase of its investigations.
The Commission will issue a final phase
notice of scheduling, which will be
published in the Federal Register as
provided in section 207.21 of the
Commission’s rules, upon notice from
the Department of Commerce
(‘‘Commerce’’) of affirmative
preliminary determinations in the
investigations under sections 703(b) or
733(b) of the Act, or, if the preliminary
determinations are negative, upon
notice of affirmative final
determinations in those investigations
under sections 705(a) or 735(a) of the
Act. Parties that filed entries of
appearance in the preliminary phase of
the investigations need not enter a
separate appearance for the final phase
of the investigations. Industrial users,
and, if the merchandise under
investigation is sold at the retail level,
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
E:\FR\FM\20MYN1.SGM
20MYN1
31959
Federal Register / Vol. 81, No. 98 / Friday, May 20, 2016 / Notices
representative consumer organizations
have the right to appear as parties in
Commission antidumping and
countervailing duty investigations. The
Secretary will prepare a public service
list containing the names and addresses
of all persons, or their representatives,
who are parties to the investigations.
Background
On March 31, 2016, Compass
Chemical International LLC, Smyrna,
Georgia, filed a petition with the
Commission and Commerce, alleging
that an industry in the United States is
materially injured or threatened with
material injury by reason of LTFV and
subsidized imports of 1hydroxyethylidene-1, 1-diphosphonic
acid from China. Accordingly, effective
March 31, 2016, the Commission,
pursuant to sections 703(a) and 733(a) of
the Tariff Act of 1930 (19 U.S.C.
1671b(a) and 1673b(a)), instituted
countervailing duty investigation No.
701–TA–558 and antidumping duty
investigation No. 731–TA–1316
(Preliminary).
Notice of the institution of the
Commission’s investigations and of a
public conference to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register of April 7, 2016 (81 FR
20416). The conference was held in
Washington, DC, on April 21, 2016, and
all persons who requested the
opportunity were permitted to appear in
person or by counsel.
The Commission made these
determinations pursuant to sections
703(a) and 733(a) of the Tariff Act of
1930 (19 U.S.C. 1671b(a) and 1673b(a)).
It completed and filed its
determinations in these investigations
on May 16, 2016. The views of the
Commission are contained in USITC
Publication 4612 (May 2016), entitled 1Hydroxyethylidene-1, 1-Diphosphonic
Acid from China: Investigation Nos.
701–TA–558 and 731–TA–1316
(Preliminary).
By order of the Commission.
Issued: May 16, 2016.
Lisa R. Barton,
Secretary to the Commission.
mstockstill on DSK3G9T082PROD with NOTICES
[FR Doc. 2016–11891 Filed 5–19–16; 8:45 am]
BILLING CODE 7020–02–P
Drug Enforcement Administration
Dated: May 16, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[Docket No. DEA–392]
[FR Doc. 2016–11939 Filed 5–19–16; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances Registration: Pharmacore,
Inc.
ACTION:
Drug Enforcement Administration
Notice of registration.
Pharmacore, Inc. applied to
be registered as a manufacturer of
certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants
Pharmacore, Inc. registration as a
manufacturer of those controlled
substances.
SUMMARY:
By notice
dated January 27, 2016, and published
in the Federal Register on February 4,
2016, 81 FR 6044, Pharmacore, Inc.,
4180 Mendenhall Oaks Parkway, High
Point, North Carolina 27265 applied to
be registered as a manufacturer of
certain basic classes of controlled
substances. No comments or objections
were submitted for this notice.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of Pharmacore, Inc. to
manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Oxymorphone (9652) ....................
Noroxymorphone (9668) ...............
DEPARTMENT OF JUSTICE
Schedule
II
II
The company plans to manufacture
the listed controlled substances as
active pharmaceutical ingredients (APIs)
for clinical trials.
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Mallinckrodt,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before July 19, 2016.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
February 19, 2016, Mallinckrodt, LLC,
3600 North Second Street, Saint Louis,
Missouri 63147 applied to be registered
as a bulk manufacturer of the following
basic classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Schedule
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Codeine-N-oxide (9053) ..............................................................................................................................................................................
Dihydromorphine (9145) ..............................................................................................................................................................................
Difenoxin (9168) ..........................................................................................................................................................................................
VerDate Sep<11>2014
17:40 May 19, 2016
Jkt 238001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
E:\FR\FM\20MYN1.SGM
20MYN1
I
I
I
I
I
Agencies
[Federal Register Volume 81, Number 98 (Friday, May 20, 2016)]
[Notices]
[Pages 31958-31959]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11891]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation Nos. 701-TA-558 and 731-TA-1316 (Preliminary)]
1-Hydroxyethylidene-1, 1-Diphosphonic Acid From China;
Determinations
On the basis of the record \1\ developed in the subject
investigations, the United States International Trade Commission
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the
Act''), that there is a reasonable indication that an industry in the
United States is threatened with material injury by reason of imports
of 1-hydroxyethylidene-1, 1-diphosphonic acid (``HEDP'') from China,
provided for in subheading 2931.90.90 (statistical reporting number
2931.90.9043) of the Harmonized Tariff Schedule of the United States,
that are alleged to be sold in the United States at less than fair
value (``LTFV'') and are allegedly subsidized by the government of
China.
---------------------------------------------------------------------------
\1\ The record is defined in sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------
Commencement of Final Phase Investigations
Pursuant to section 207.18 of the Commission's rules, the
Commission also gives notice of the commencement of the final phase of
its investigations. The Commission will issue a final phase notice of
scheduling, which will be published in the Federal Register as provided
in section 207.21 of the Commission's rules, upon notice from the
Department of Commerce (``Commerce'') of affirmative preliminary
determinations in the investigations under sections 703(b) or 733(b) of
the Act, or, if the preliminary determinations are negative, upon
notice of affirmative final determinations in those investigations
under sections 705(a) or 735(a) of the Act. Parties that filed entries
of appearance in the preliminary phase of the investigations need not
enter a separate appearance for the final phase of the investigations.
Industrial users, and, if the merchandise under investigation is sold
at the retail level,
[[Page 31959]]
representative consumer organizations have the right to appear as
parties in Commission antidumping and countervailing duty
investigations. The Secretary will prepare a public service list
containing the names and addresses of all persons, or their
representatives, who are parties to the investigations.
Background
On March 31, 2016, Compass Chemical International LLC, Smyrna,
Georgia, filed a petition with the Commission and Commerce, alleging
that an industry in the United States is materially injured or
threatened with material injury by reason of LTFV and subsidized
imports of 1-hydroxyethylidene-1, 1-diphosphonic acid from China.
Accordingly, effective March 31, 2016, the Commission, pursuant to
sections 703(a) and 733(a) of the Tariff Act of 1930 (19 U.S.C.
1671b(a) and 1673b(a)), instituted countervailing duty investigation
No. 701-TA-558 and antidumping duty investigation No. 731-TA-1316
(Preliminary).
Notice of the institution of the Commission's investigations and of
a public conference to be held in connection therewith was given by
posting copies of the notice in the Office of the Secretary, U.S.
International Trade Commission, Washington, DC, and by publishing the
notice in the Federal Register of April 7, 2016 (81 FR 20416). The
conference was held in Washington, DC, on April 21, 2016, and all
persons who requested the opportunity were permitted to appear in
person or by counsel.
The Commission made these determinations pursuant to sections
703(a) and 733(a) of the Tariff Act of 1930 (19 U.S.C. 1671b(a) and
1673b(a)). It completed and filed its determinations in these
investigations on May 16, 2016. The views of the Commission are
contained in USITC Publication 4612 (May 2016), entitled 1-
Hydroxyethylidene-1, 1-Diphosphonic Acid from China: Investigation Nos.
701-TA-558 and 731-TA-1316 (Preliminary).
By order of the Commission.
Issued: May 16, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016-11891 Filed 5-19-16; 8:45 am]
BILLING CODE 7020-02-P